Insider plans $2.54M Zoetis (ZTS) Rule 144 stock sale via options

Rhea-AI Filing Summary

Zoetis Inc. insider plans Rule 144 sale of common stock. A holder has filed to sell 20,000 shares of Zoetis common stock through Merrill Lynch on the NYSE, with an aggregate market value of $2,540,963.98 and 422,127,709 Zoetis shares outstanding.

The shares were acquired on 02/17/2026 by exercising employee stock options in a broker-assisted cashless exercise, and the approximate sale date listed is also 02/17/2026. The filer represents they are not aware of any undisclosed material adverse information about Zoetis.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch 225 Liberty Street Floor 37 New York NY 10281	20000	2540963.98	422127709	02/17/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/17/2026	Exercise of employee stock options	Zoetis Inc.			20000	02/17/2026	Broker assisted cashless exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Zoetis (ZTS) Form 144 filing disclose?

The Form 144 discloses that a holder intends to sell 20,000 shares of Zoetis common stock under Rule 144. The planned NYSE sale uses Merrill Lynch as broker, with an aggregate market value of $2,540,963.98 based on the figures in the notice.

How many Zoetis (ZTS) shares are covered by this planned Rule 144 sale?

The notice covers a proposed sale of 20,000 Zoetis common shares. This amount is listed as the number of shares to be sold, compared with 422,127,709 Zoetis shares outstanding, giving a sense of scale relative to the company’s total common stock.

How were the Zoetis (ZTS) shares in the Form 144 acquired?

The 20,000 Zoetis common shares were acquired on 02/17/2026 through the exercise of employee stock options. The filing specifies a broker-assisted cashless exercise, meaning the broker facilitated exercising options and handling shares and proceeds in a single coordinated transaction.

When is the approximate sale date for the Zoetis (ZTS) Form 144 shares?

The approximate date of sale stated is 02/17/2026. This date appears both as the acquisition date via employee stock option exercise and as the expected sale date, indicating a same-day cashless exercise and planned disposition under Rule 144 on the NYSE.

Which broker and exchange are involved in the Zoetis (ZTS) Form 144 transaction?

Merrill Lynch, located at 225 Liberty Street, Floor 37, New York, NY 10281, is listed as the broker for the transaction. The securities exchange named is the NYSE, where the 20,000 Zoetis common shares are intended to be sold under Rule 144.

What representation does the Zoetis (ZTS) Form 144 filer make about inside information?

The person for whose account the Zoetis shares are to be sold represents that they do not know any material adverse information about Zoetis’s current or prospective operations that has not been publicly disclosed, consistent with Rule 144 and related securities law requirements.